Pre-close Trading Update

RNS Number : 2350Q

Oxford Instruments PLC

07 April 2009

 



7 April 2009

Pre-close Trading Update 

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research ("Oxford Instruments" or "the Group"), is today issuing a trading statement ahead of entering its close period.

The Board is confident that the Group's full year performance is in line with its expectations. 

Oxford Instruments' preliminary results for the year ended 31 March 2009 will be released on Tuesday 9 June.

Ends

Enquiries:

Oxford Instruments plc	Tel: [phone]
Jonathan Flint	Chief Executive
Kevin Boyd	Group Finance Director

Hogarth Partnership	Tel: [phone]
Rachel Hirst
Andrew Jaques

Notes to Editors

Oxford Instruments designs, supplies and supports high-technology tools, processes and solutions with a focus on physical science, bioscience, environmental and industrial research and applications. It provides solutions needed to advance fundamental nanoscience research and its transfer into commercial nanotechnology applications. Innovation has been the driving force behind Oxford Instruments' growth and success for 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion. 

The first technology business to be spun out from Oxford University fifty years ago, Oxford Instruments is now a global company with over 1,300 staff worldwide and a listing on the London Stock Exchange (OXIG). Its objective is to be the leading provider of new generation tools and systems for the Physical Science and Bioscience sectors.

This involves the combination of core technologies in areas such as low temperature and high magnetic field environments, Nuclear Magnetic Resonance, X-ray electron and optical based metrology, and advanced growth, deposition and etching. Our products, expertise, and ideas address global issues such as energy, environment, terrorism and health and are part of the next generation of telecommunications, energy products, environmental measures, security devices, drug discovery and medical advances.

 

END

 

 

TSTCKAKQABKDPQK